Number and Percentage of Lesions Rated as Malignant on 18F-PSMA-1007 PET and 68Ga-PSMA-11 PET According to Their Origin
| 68Ga-PSMA-11 PET | 18F-PSMA-1007 PET | |||
| Parameter | Patients | Lesions | Patients | Lesions |
| Total patients | 82/102 (80.4%) | 126 | 82/102 (80.4%) | 124 |
| Local recurrence | 33/102 (32.4%) | 33/126 (26.2%) | 27/102 (26.5%) | 27/124 (21.8%) |
| LN metastasis | 51/102 (50.0%) | 64/126 (50.8%) | 55/102 (53.9%) | 70/124 (56.5%) |
| Abdominopelvic | 43 | 36 | ||
| Supradiaphragmatic | 21 | 34 | ||
| Bone metastases | 26/102 (25.5%) | 26/126 (20.6%) | 22/102 (21.6%) | 22/124 (17.7%) |
| Other metastases | 3/102 (2.9%) | 3/126 (2.3%) | 5/102 (4.9%) | 5/124 (4.0%) |